GLP-1 and GIP Agonists: A Triple Ripple in Obesity Medication
Dr. David Lawrence here…
In this series, I want to talk about GLP-1 agonists and GIP agonists, as well as the new third-generation medication called Retatrutide. These medications have shown promising results in the treatment of type 2 diabetes and obesity. I’ll explain how they work, their side effects, and the potential for long-term weight loss. So let’s dive in!
Semaglutide: A First-Generation GLP-1 Agonist
Semaglutide: A First-Generation GLP-1 Agonist Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and obesity. It works as a GLP-1 agonist, increasing insulin secretion and improving blood sugar control. By slowing down digestion,...
Tirzepatide: A Second-Generation Medication
Tirzepatide: A Second-Generation Medication Tirzepatide is another medication used to improve blood sugar control in adults. It has a greater affinity for GIP receptors than GLP-1 receptors, making it more effective in reducing hyperglycemia. Studies have shown that...
The Promise of Retatrutide
The Promise of Retatrutide In the pipeline, there's an experimental drug called Retatrutide, which is showing promising results in Phase II clinical trials. Also known as LY-3437943, Retatrutide is a triple hormone receptor against GLP-1, GIP, and GCR-GR receptors....
Addressing Concerns About Muscle Loss
Addressing Concerns About Muscle Loss Some individuals have expressed concerns about muscle loss while taking these medications. However, maintaining muscle mass is crucial for metabolism and longevity. By combining Semaglutide and Tirzepatide weight loss therapy with...
Optimizing Health with Vitamin Supplements
Optimizing Health with Vitamin Supplements While on these medications, it's important to monitor vitamin D and B12 levels. Studies have shown that supplementation with oral vitamins is not effective in raising deficient levels. Injection-based supplementation is more...